Improving the managed entry of new medicines: sharing experiences across Europe

被引：0

作者：

Godman, Brian ^{[1
,2
,3
]}

Paterson, Ken ^{[4
]}

Malmstrom, Rickard E. ^{[5
]}

Selke, Gisbert ^{[6
]}

Fagot, Jean-Paul ^{[7
]}

Mrak, Jana ^{[8
]}

机构：

[1] Karolinska Univ, Huddinge Hosp, Div Clin Pharmacol, Stockholm, Sweden

[2] Mario Negri Inst Pharmacol Res, Milan, Italy

[3] Univ Liverpool, Prescribing Res Grp, Sch Management, Liverpool L69 3BX, Merseyside, England

[4] Scottish Med Consortium, Glasgow, Lanark, Scotland

[5] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Div Clin Pharmacol, Stockholm, Sweden

[6] AOK WidO, Wissensch Inst, Berlin, Germany

[7] Caisse Natl Assurance Maladie Travailleurs Salari, DSES, DEPP, Paris, France

[8] Hlth Insurance Inst Slovenia, Ljubljana, Slovenia

来源：

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2012年 / 12卷 / 04期

关键词：

demand-side measures; horizon scanning; HTA; indicators; managed entry; pharmaceuticals; RECOMMENDATIONS; CARE; RISK;

D O I：

10.1586/ERP.12.44

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The Managed Introduction of New Medicines Ljubljana, Slovenia, 19-21 March 2012 The 3-day course on the managed entry of new medicines was run by the Piperska group, which is a pan-European group striving to enhance the health of the public as a whole and the individual patient through exchanging ideas and research around the rational use of drugs. Participants included health authority and health insurance personnel, academics and those from commercial organizations. The principal aim of the conference was to bring together people to discuss ways to improve the managed entry of new drugs.

引用

页码：439 / 441

页数：3

共 50 条

[21] How Managed Entry Agreements Influence the Patients' Affordability to Biological Medicines-Bulgarian Example
Mitkova, Zornitsa
Manev, Ivan
Tachkov, Konstantin
Boyadzhieva, Vladimira
Stoilov, Nikolay
Doneva, Miglena
Petrova, Guenka
HEALTHCARE, 2023, 11 (17)
[22] Managing the entry of new medicines in the National Health Service: health authority experiences and prospects for primary care groups and trusts
McDonald, R
Burrill, P
Walley, T
HEALTH & SOCIAL CARE IN THE COMMUNITY, 2001, 9 (06) : 341 - 347
[23] Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe
Jommi, Claudio
Bertolani, Arianna
Armeni, Patrizio
Costa, Francesco
Otto, Monica
HEALTH POLICY AND TECHNOLOGY, 2023, 12 (03)
[24] A study of regulations combating counterfeit medicines across India, USA, and Europe
Nori, Lakshmi Prasanthi
Varma, T. Srinivas
Nulu, Lakshmi Sri Naga Valli
Raju, K. Venkateswara
ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2023, 15 (02) : 115 - 123
[25] Europaweit einheitliche Preisgestaltung bei MedikamentenStandardized Pricing of Medicines Across Europe
Rudolf Likar
Schmerz Nachrichten, 2022, 22 (2): : 63 - 63
[26] Improving affordability of new Essential Cancer Medicines
t'Hoen, Ellen
Meyer, Salome
Durisch, Patrick
Bannenberg, Wilbert
Perehudoff, Katrina
Reed, Tim
Barber, Melissa J.
LANCET ONCOLOGY, 2019, 20 (08): : 1052 - 1054
[27] Improving access to medicines for early medical abortion: learning from experiences of medicines licensing and service delivery
Rowlands, Sam
Harrison-Woolrych, Mira
BMJ SEXUAL & REPRODUCTIVE HEALTH, 2023, 49 (04) : 234 - 237
[28] Austerity across Europe: Lived experiences of economic crises
Lanau, Alba
SOCIAL POLICY & ADMINISTRATION, 2022, 56 (06) : 972 - 973
[29] Children as Decision Makers in Education: Sharing Experiences across Cultures
Alderson, Priscilla
COMPARATIVE EDUCATION REVIEW, 2011, 55 (01) : 143 - 145
[30] Sharing Enriched Multimedia Experiences across Heterogeneous Network Infrastructures
Hesselman, Cristian
Abbadessa, Daniele
van der Beek, Wouter
Gorgen, Daniel
Shepherd, Keir
Smit, Sander
Guelbahar, Mark
Vaishnavi, Ishan
Zoric, Josip
Lowet, Dietwig
de Groote, Robert
O'Connell, John
Friedrich, Oliver
IEEE COMMUNICATIONS MAGAZINE, 2010, 48 (06) : 54 - 65

← 1 2 3 4 5 →